Home
Business
Corporate Finance
Asset Management
Wealth Management
Global Markets
Structured Finance
Research
Daily Note
Market Strategy
Macroeconomics
Securities Analysis
Customer Trading
Stock Trading
Futures Trading
Options Trading
Virtual Assets Trading
Company News
About CMBI
Company Profile
Join Us
Contact Us
English
Simplified Chinese
Traditional Chinese
English
Home
>
Research
>
Securities Analysis
【公司研究】中国生物制药 (1177 HK) - PDE3/4抑制剂 II期临床数据亮眼,市场潜力巨大
Click to read the report